Our research in Leeds
Our researchers at the University of Leeds have a superb track record in the field of cancer genetics. They are investigating how our genes and lifestyle combine to influence our risk of developing cancer. Other research at St James’s University Hospital aims to develop new treatments for a wide range of cancers, including bowel cancer.
We also fund the clinical trials work of the Children’s Cancer and Leukaemia Group (CCLG) at the St James's University Hospital in Leeds. The group co-ordinates the care of virtually all the UK’s children with cancer, ensuring they receive the most up-to-date treatments.
All cancer types
Dr Galina Velikova
Psychosocial Oncology Group, Cancer Research UK Clinical Centre
St James' University Hospital, Leeds
Monitoring patient well-being
Dr Galina Velikova leads the Psychosocial Oncology Group at the University of Leeds. Her research focuses on monitoring the well-being of people diagnosed with cancer and those undergoing treatment.
Bladder cancer
Prof Maggie Knowles
Cancer Research UK Clinical Centre
University of Leeds, Leeds
Investigating bladder cancer
Professor Maggie Knowles is at the forefront of research into bladder cancer. She is investigating the genes and proteins involved in the development of this disease.
Bowel cancer
Prof Matt Seymour
School of Medicine
University of Leeds, Leeds
Testing new treatments for bowel cancer
Matt Seymour is Professor of Gastrointestinal Cancer Medicine at the University of Leeds. His team carry out clinical trials testing new treatments for bowel cancer and cancers of other parts of the digestive system including the stomach and pancreas. Professor Seymour is especially interested in developing treatments with fewer side effects to give patients the best possible quality of life. He is also working to develop tests to select the best treatments for individual patients.
Breast cancer
Prof Peter Selby
Section of Oncology and Clinical Research
Leeds Institute of Molecular Medicine, Leeds
Developing and testing new ways to treat cancer
Professor Peter Selby is head of the Section of Oncology and Clinical Research at the University of Leeds. Teams in this department are carrying out lab studies into treatments for many types of cancer, including breast, ovarian, and melanoma skin cancer. Professor Selby also directs the Cancer Research UK Clinical Centre in Leeds, which brings cancer scientists and doctors together to develop new approaches to cancer care and test these in clinical trials.
Kidney cancer
Prof Peter Selby
Section of Oncology and Clinical Research
Leeds Institute of Molecular Medicine, Leeds
Developing and testing new ways to treat cancer
Professor Peter Selby is head of the Section of Oncology and Clinical Research at the University of Leeds. Teams in this department are carrying out lab studies into treatments for many types of cancer, including breast, ovarian, and melanoma skin cancer. Professor Selby also directs the Cancer Research UK Clinical Centre in Leeds, which brings cancer scientists and doctors together to develop new approaches to cancer care and test these in clinical trials.
Melanoma
Prof Julia Newton-Bishop
Section of Biostatistics and Epidemiology, Leeds Institute of Molecular Medicine,
St James's Hospital/University of Leeds, Leeds
Finding skin cancer genes
Professor Julia Newton-Bishop works in the Section of Biostatistics and Epidemiology of the Leeds Institute of Molecular Medicine. She studies people with family histories of melanoma skin cancer.
Prof Peter Selby
Section of Oncology and Clinical Research
Leeds Institute of Molecular Medicine, Leeds
Developing and testing new ways to treat cancer
Professor Peter Selby is head of the Section of Oncology and Clinical Research at the University of Leeds. Teams in this department are carrying out lab studies into treatments for many types of cancer, including breast, ovarian, and melanoma skin cancer. Professor Selby also directs the Cancer Research UK Clinical Centre in Leeds, which brings cancer scientists and doctors together to develop new approaches to cancer care and test these in clinical trials.
Increase text
Decrease text
Print this page
